"Herd immunity" and the meningococcal vaccine trial in Norway. 1992

G Bjune

UI MeSH Term Description Entries
D008589 Meningococcal Infections Infections with bacteria of the species NEISSERIA MENINGITIDIS. Meningococcal Septicemia,Infections, Meningococcal,Meningococcal Disease,Infection, Meningococcal,Meningococcal Diseases,Meningococcal Infection,Septicemia, Meningococcal
D009664 Norway A country located in northern Europe, bordering the North Sea and the Atlantic Ocean, west of Sweden. The capital is Oslo. Kingdom of Norway
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D001428 Bacterial Vaccines Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease. Bacterial Vaccine,Bacterin,Vaccine, Bacterial,Vaccines, Bacterial
D022401 Meningococcal Vaccines Vaccines or candidate vaccines used to prevent infection with NEISSERIA MENINGITIDIS. Bivalent Meningococcal Vaccine,Menactra,Meningococcal Polysaccharide Vaccine,Meningococcal Vaccine,Menomune,Menveo,Tetravalent Meningococcal Vaccine,Meningococcal Vaccine, Bivalent,Meningococcal Vaccine, Tetravalent,Polysaccharide Vaccine, Meningococcal,Vaccine, Meningococcal,Vaccine, Meningococcal Polysaccharide,Vaccines, Meningococcal

Related Publications

G Bjune
March 2000, Lancet (London, England),
G Bjune
March 2000, Lancet (London, England),
G Bjune
March 2000, Lancet (London, England),
G Bjune
November 1999, Lancet (London, England),
G Bjune
December 1991, Lancet (London, England),
G Bjune
February 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
G Bjune
May 2020, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
G Bjune
October 2004, Current infectious disease reports,
G Bjune
January 2023, International journal of preventive medicine,
Copied contents to your clipboard!